| Amesika N Nyaku, MD, MS | |
|
150 Bergen St, D Level, Newark, NJ 07103-2496 | |
| (973) 972-5111 | |
| (973) 972-3102 |
| Full Name | Amesika N Nyaku |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 14 Years |
| Location | 150 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134440647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 25MA09952700 (New Jersey) | Secondary |
| 207R00000X | Internal Medicine | 25MA09952700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The University Hospital | Newark, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physician Associates Of New Jersey Inc | 9830003417 | 320 |
News Archive
A trauma surgeon for more than 20 years, Esposito has witnessed the tragic aftermath of drunken walking professionally and personally. Several years ago, Esposito's cousin of his opted to walk instead of driving home from a party where he had been drinking.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury.
A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.
› Verified 9 days ago
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760492367 PECOS PAC ID: 9830003417 Enrollment ID: O20031118000289 |
News Archive
A trauma surgeon for more than 20 years, Esposito has witnessed the tragic aftermath of drunken walking professionally and personally. Several years ago, Esposito's cousin of his opted to walk instead of driving home from a party where he had been drinking.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury.
A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amesika N Nyaku, MD, MS 150 Bergen St, D Level, Newark, NJ 07103-2496 Ph: (973) 972-5111 | Amesika N Nyaku, MD, MS 150 Bergen St, D Level, Newark, NJ 07103-2496 Ph: (973) 972-5111 |
News Archive
A trauma surgeon for more than 20 years, Esposito has witnessed the tragic aftermath of drunken walking professionally and personally. Several years ago, Esposito's cousin of his opted to walk instead of driving home from a party where he had been drinking.
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury.
A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.
› Verified 9 days ago
Dr. Xiaoning Joanie Zhu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Lissette Maria Cespedes, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Msb I588, Newark, NJ 07103 Phone: 973-972-3479 | |
Dr. Pankaja Achar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Internal Medicine Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |